These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9533558)
1. Ineffectiveness of oral coenzyme Q10 supplementation in 3-methylglutaconic aciduria, type 3. Costeff H; Apter N; Elpeleg ON; Prialnic M; Böhles HJ Brain Dev; 1998 Jan; 20(1):33-5. PubMed ID: 9533558 [TBL] [Abstract][Full Text] [Related]
2. 3-Methylglutaconic aciduria in the Iraqi-Jewish 'optic atrophy plus' (Costeff) syndrome. Elpeleg ON; Costeff H; Joseph A; Shental Y; Weitz R; Gibson KM Dev Med Child Neurol; 1994 Feb; 36(2):167-72. PubMed ID: 7510656 [TBL] [Abstract][Full Text] [Related]
3. 3-Methylglutaconic aciduria in "optic atrophy plus". Costeff H; Elpeleg O; Apter N; Divry P; Gadoth N Ann Neurol; 1993 Jan; 33(1):103-4. PubMed ID: 8494328 [TBL] [Abstract][Full Text] [Related]
4. Cardiac performance and coenzyme Q10 in thyroid disorders. Suzuki H; Naitoh T; Kuniyoshi S; Banba N; Kuroda H; Suzuki Y; Hiraiwa M; Yamazaki N; Ishikawa M; Hashigami Y Endocrinol Jpn; 1984 Dec; 31(6):755-61. PubMed ID: 6532793 [TBL] [Abstract][Full Text] [Related]
5. Plasma ubiquinone status and response to six-month supplementation combined with multivitamins in healthy elderly women--results of a randomized, double-blind, placebo-controlled study. Wolters M; Hahn A Int J Vitam Nutr Res; 2003 May; 73(3):207-14. PubMed ID: 12847998 [TBL] [Abstract][Full Text] [Related]
6. The effect of coenzyme Q10 in patients with congestive heart failure. Khatta M; Alexander BS; Krichten CM; Fisher ML; Freudenberger R; Robinson SW; Gottlieb SS Ann Intern Med; 2000 Apr; 132(8):636-40. PubMed ID: 10766682 [TBL] [Abstract][Full Text] [Related]
7. Effects of coenzyme Q10 supplementation on antioxidant capacity and inflammation in hepatocellular carcinoma patients after surgery: a randomized, placebo-controlled trial. Liu HT; Huang YC; Cheng SB; Huang YT; Lin PT Nutr J; 2016 Oct; 15(1):85. PubMed ID: 27716246 [TBL] [Abstract][Full Text] [Related]
8. Coenzyme Q10 in the diet--daily intake and relative bioavailability. Weber C; Bysted A; Hølmer G Mol Aspects Med; 1997; 18 Suppl():S251-4. PubMed ID: 9266531 [TBL] [Abstract][Full Text] [Related]
9. A one year bioavailability study of coenzyme Q10 with 3 months withdrawal period. Folkers K; Moesgaard S; Morita M Mol Aspects Med; 1994; 15 Suppl():s281-5. PubMed ID: 7752840 [TBL] [Abstract][Full Text] [Related]
12. Coenzyme Q10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia. Niklowitz P; Menke T; Wiesel T; Mayatepek E; Zschocke J; Okun JG; Andler W Clin Chim Acta; 2002 Dec; 326(1-2):155-61. PubMed ID: 12417107 [TBL] [Abstract][Full Text] [Related]
13. Serum concentration of lipoprotein(a) decreases on treatment with hydrosoluble coenzyme Q10 in patients with coronary artery disease: discovery of a new role. Singh RB; Niaz MA Int J Cardiol; 1999 Jan; 68(1):23-9. PubMed ID: 10077397 [TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. Burke BE; Neuenschwander R; Olson RD South Med J; 2001 Nov; 94(11):1112-7. PubMed ID: 11780680 [TBL] [Abstract][Full Text] [Related]
15. The effect of coenzyme Q10 on the exercise performance of cross-country skiers. Ylikoski T; Piirainen J; Hanninen O; Penttinen J Mol Aspects Med; 1997; 18 Suppl():S283-90. PubMed ID: 9266538 [TBL] [Abstract][Full Text] [Related]